국내 1, 2차 의료기관의 임상검체에서 분리된 Pseudomonas aeruginosa 항균제 내성, 2002-2004

참고문헌 (52)

1. "Pseudomonas aeruginosa, In Mandell GL, Bennettt JE, Dolin RM, eds. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases,", pp.2310~2335 (2000), Churchill Livingstone
2. "Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units:evaluation of a National Postmarketing Surveillance Program", 23, pp.779~784 (1996)
3. "A nationwide survey on the causative organisms of neonatal sepsis in Korea", 45, pp.55~63 (2002)
4. "National Nosocomial Infections Surveillance (NNIS) system report", 32, pp.470~485 (2004)
5. "Surveillance of antibiotic resistance in European ICUs", 48, pp.161~176 (2001)
6. "Antimicrobial susceptibility profiles of Pseudomonas aeruginosa and Staphylococcus aureus isolated in Italy from patients with hospital- acquired infections", 24, pp.515~518 (2004)
7. "Korean Nationwide Surveillance of Antimicrobial Resistance Group Increasing prevalence of vancomycin-resistant enterococci A KONSAR Study on 2002", 45, pp.598~608 (2004)
8. "Study of results of bacterial culture and antibiotic sensitivity in burn patients", 39, pp.1391~1396 (2001)
9. "Epidemiological study of Pseudomonas aeruginosa isolated in the hospital: colonial characteristics, antibiotic resistance and PFGE patterns", 19, pp.680~688 (1999)
10. "Geographic variations in activity of borad-spectrum β-lactams against Paseudomonas aeruginosa summary of the worldwide SENTRY Antimicrobial Surveillance Program(1997-2001).", 43, pp.239~243 (2002)
11. "Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit report from the SENTRY Anitmicrobial Surveillance Program(North America, 2001).", 24, pp.111~118 (2004)
12. "Pseudomonas aeruginosa community-acquired pneumonia in previously healthy adults:case report and review of the literature", 31, pp.1349~1356 (2000)
13. "A case of severe community-acquired pneumonia due to Pseudomonas aeruginosa in a Healthy Adult", 32, pp.248~251 (2000)
14. "Contemporary in vitro spectrum of activity summary for antimicrobial agents tested against 18569 strains non- fermentative gram-negative bacilli isolated in the SENTRY Antimicrobial Surveillance Program(1997-2001)", 22, pp.551~556 (2003)
15. "Persistence of a multidrug-resistant Pseudomonas aeruginosa clone in an intensive care burn unit", 36, pp.1347~1351 (1998)
16. "Pseudomonas aeruginosa outbreak in a burn unit:role of antimicrobials in the emergence of multiply resistant strains", 170, pp.377~83 (1994)
17. "The resistance to ciprofloxacin in bacterial ocular disease", 42, pp.576~582 (2001)
18. "Outbreak of nosocomial urinary tract infections caused by multidrug-resistant Pseudomonas aeruginosa", 4, pp.1~6 (1999)
19. "Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram- negative bacteria", 27, pp.93~99 (1998)
20. "Extended-spectrum β- lactamases in Pseudomonas aeruginosa", 42, pp.128~132 (1998)
21. "Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa:our worst nightmare?", 34, pp.634~640 (2002)
22. "Evolution of an integron carrying blaVIM-2 in Eastern Europe:report from the SENTRY Antimicrobial Surveillance Program", 52, pp.116~119 (2003)
23. "Clinical problems posed by multiresistant nonfermenting gram-negative pathogens", 27, pp.117~124 (1998)
24. "Emergence of antibiotic-resistant Pseudomonas aeruginosa:comparison of risks associated with different antipseudomonal agents", 43, pp.1379~1382 (1999)
25. "Increasing prevalence of antimicrobial resistance among Pseudomonas aeruginosa isolates in Latin American medical centers 5", 52, pp.140~141 (2003)
26. "Characterization of Pseudomonas aeruginosa isolates and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999", 32, pp.146~155 (2001)
27. "MYSTIC Program Study Group : Antimicrobial resistance trends in medical centers using carbapenems", 41, pp.177~182 (2001)
28. "Antimicrobial susceptibility of Pseudomonas aeruginosa results of a UK survey and evaluation of the British Society for antimicrobial chemotherapy disc susceptibility test", 47, pp.789~799 (2001)
29. "Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from Hospitalized patients in the United States,1998 to 2001", 47, pp.1681~1688 (2003)
30. "The need for antimicrobial resistancesurveillance", 50, pp.1~7 (2002)
31. "The current status of surveillance of resistance to antimicrobial agents:report on a meeting", 49, pp.17~23 (2002)
32. "Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard" (2003)
33. "Modified Hodge and EDTA-disk synergy tests to screen metallo-β-lactamase-producing strains of Pseudomonas and Acinetobacter species", 7, pp.88~91 (2001)
34. "Antimicrobial resistance of clinical isolates of Acinetobacter spp.collected from non-tertiary hospitals and detection of a metallo-β-lactamase-producing strain", 36, pp.271~278 (2004)
35. "Antibiotic resistance for common hospital acquired-pneumonia pathogens in the intensive care unit of newly opened hospital", 52, pp.207~218 (2002)
36. "Korean nationwide surveillance of antimicrobial resistance in 2000 with special reference to vancomycin resistance in enterococci,and expanded-spectrum cephalosporin and imipenem resistance in gram- negative bacilli", 44, pp.571~578 (2003)
37. "Korean Nationwide Surveillance of Antimicrobial Resistance Group Increasing prevalence of vancomycin-resistant Enterococcus faecium and imipenem-resistant Pseudomonas aeruginosa in Korea", 19, pp.8~14 (2004)
38. "Antimicrobial resistance of clinically important bacteria isolated from hospitals located in representative provinces of Korea", 6, pp.29~36 (2003)
39. "Antimicrobial resistance of clinically important bacteria isolated from 12 hospitals in Korea", 7, pp.171~177 (2004)
40. "Antibiotic resistance patterns of Staphylococcus aureus isolated from the patients admitted to non-tertiary hospitals", 32, pp.259~264 (2000)
41. "Stable antimicrobial susceptibility rates for clinical isolates of P aeruginosa from the 2001-2003 tracking resistance in the United States Today Surveillance Studies", 40, pp.89~98 (2005)
42. "Surveillance for antimicrobial resistance among clinical isolates of Gram-negative bacteria from intensive care unit patients in China 1999 to 2002", 51, pp.201~208 (2005)
43. "Outer membrane proteins responsible for multiple drug resistance in Pseudomonas aeruginosa", 39, pp.645~649 (1995)
44. "Multidrug efflux in Pseudomonas aeruginosa: components, mechanisms and clinical significance", 1, pp.59~71 (2001)
45. "Clinical problems posed by multiresistant nonfermenting gram-negative pathogens", 27, pp.117~124 (1998)
46. "Metallo-β-lactmase; a class apart", 27, pp.48~53 (1998)
47. "Mechanisms of β-lactam resistance amongst Pseudomonas aeruginosa isolated in an Italian survey", 42, pp.697~702 (1998)
48. "Korean Nationwide Surveillance of Antimicrobial Resistance Group : VIM-and IMP-type metallo-β- lactamase-producing Pseudomonas spp. and Acinetobacter spp. in Korean hospitals", 9, pp.868~871 (2003)
49. "Korean Nationwide Surveillance of Antimicrobial Resistance Group Metallo-β-lactmase-producing gram-negative bacilli in Korean Nationwide Surveillance of Antimicrobial Resistance group hospitals in 2003 continued prevalence of VIM-producing Pseudomonas spp and increase of IMP-producing Acinetobacter spp", 50, pp.51~58 (2004)
50. "Prevalence of metallo-β- lactamase among Pseudomonas aeruginosa and Acinetobacter baumannii in a Korean university hospital and comparison of screening methods for detecting metallo-β-lactamase", 54, pp.411~418 (2003)
51. "Multifocal outbreaks of metallo-β-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum β-lactams,including carbapenems", 40, pp.349~353 (1996)
52. "A novel integron-like element carrying the metallo- β-lactamase gene blaIMP", 39, pp.1612~1615 (1995)

관련 논문AI추천